Claybrook Capital’s Globus Medical GMED Stock Holding History

Claybrook Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-82	Closed	-$4K	–	317
2018 Q4	$4K	Buy	+82	New	+$4.09K	﹤0.01%	592

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Claybrook Capital's GMED Position: Q1 2019 in Review

Claybrook Capital sold out of Globus Medical (GMED) in Q1 2019, closing a stake of 82 shares — an estimated $4K sold.

Claybrook Capital first reported a position in GMED in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 269 funds tracked by Wall St. Rank hold GMED as of Q1 2019.

Claybrook Capital reported no remaining Globus Medical position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 82 Globus Medical shares in Q1 2019, an estimated $4K.
Claybrook Capital first reported a position in Globus Medical in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Globus Medical position peaked at $4K in Q4 2018.
269 funds tracked by Wall St. Rank held Globus Medical as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.